Selected research
Market Outlook & Growth Opportunities
Global Pain Patches Market Outlook and Growth Opportunities 2026
Market perspective
The global Pain Patches market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pain Patches market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pain Patches market include Sanofi, Novartis, GlaxoSmithKline, Viatris, Teva Pharmaceutical Industries, Teikoku Seiyaku, Nichiban, Mentholatum and Johnson & Johnson Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pain Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pain Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pain Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pain Patches market size, projected growth trends, production technologies, key applications, and end-use industries.
Pain Patches Segment by Company
Sanofi
Novartis
GlaxoSmithKline
Viatris
Teva Pharmaceutical Industries
Teikoku Seiyaku
Nichiban
Mentholatum
Johnson & Johnson Services
Hisamitsu Pharmaceutical
Pain Patches Segment by Type
Buprenorphine
Fentanyl
Pain Patches Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online pharmacies
Pain Patches Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Pain Patches status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pain Patches market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pain Patches significant trends, drivers, influence factors in global and regions.
6. To analyze Pain Patches competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pain Patches market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pain Patches industry.
Chapter 3: Detailed analysis of Pain Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pain Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pain Patches in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Buprenorphine
- Fentanyl
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Online pharmacies
Companies covered
- Sanofi
- Novartis
- GlaxoSmithKline
- Viatris
- Teva Pharmaceutical Industries
- Teikoku Seiyaku
- Nichiban
- Mentholatum
- Johnson & Johnson Services
- Hisamitsu Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pain Patches Sales Value (2021-2032)
- 1.2.2 Global Pain Patches Sales Volume (2021-2032)
- 1.2.3 Global Pain Patches Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Pain Patches Market Dynamics
- 2.1 Pain Patches Industry Trends
- 2.2 Pain Patches Industry Drivers
- 2.3 Pain Patches Industry Opportunities and Challenges
- 2.4 Pain Patches Industry Restraints
3 Pain Patches Market by Company
- 3.1 Global Pain Patches Company Revenue Ranking in 2025
- 3.2 Global Pain Patches Revenue by Company (2021-2026)
- 3.3 Global Pain Patches Sales Volume by Company (2021-2026)
- 3.4 Global Pain Patches Average Price by Company (2021-2026)
- 3.5 Global Pain Patches Company Ranking (2024-2026)
- 3.6 Global Pain Patches Company Manufacturing Base and Headquarters
- 3.7 Global Pain Patches Company Product Type and Application
- 3.8 Global Pain Patches Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Pain Patches Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Pain Patches Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Pain Patches Market by Type
- 4.1 Pain Patches Type Introduction
- 4.1.1 Buprenorphine
- 4.1.2 Fentanyl
- 4.2 Global Pain Patches Sales Volume by Type
- 4.2.1 Global Pain Patches Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pain Patches Sales Volume by Type (2021-2032)
- 4.2.3 Global Pain Patches Sales Volume Share by Type (2021-2032)
- 4.3 Global Pain Patches Sales Value by Type
- 4.3.1 Global Pain Patches Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pain Patches Sales Value by Type (2021-2032)
- 4.3.3 Global Pain Patches Sales Value Share by Type (2021-2032)
5 Pain Patches Market by Application
- 5.1 Pain Patches Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Retail Pharmacies
- 5.1.3 Online pharmacies
- 5.2 Global Pain Patches Sales Volume by Application
- 5.2.1 Global Pain Patches Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pain Patches Sales Volume by Application (2021-2032)
- 5.2.3 Global Pain Patches Sales Volume Share by Application (2021-2032)
- 5.3 Global Pain Patches Sales Value by Application
- 5.3.1 Global Pain Patches Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pain Patches Sales Value by Application (2021-2032)
- 5.3.3 Global Pain Patches Sales Value Share by Application (2021-2032)
6 Pain Patches Regional Sales and Value Analysis
- 6.1 Global Pain Patches Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pain Patches Sales by Region (2021-2032)
- 6.2.1 Global Pain Patches Sales by Region: 2021-2026
- 6.2.2 Global Pain Patches Sales by Region (2027-2032)
- 6.3 Global Pain Patches Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Pain Patches Sales Value by Region (2021-2032)
- 6.4.1 Global Pain Patches Sales Value by Region: 2021-2026
- 6.4.2 Global Pain Patches Sales Value by Region (2027-2032)
- 6.5 Global Pain Patches Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Pain Patches Sales Value (2021-2032)
- 6.6.2 North America Pain Patches Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Pain Patches Sales Value (2021-2032)
- 6.7.2 Europe Pain Patches Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Pain Patches Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Pain Patches Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Pain Patches Sales Value (2021-2032)
- 6.9.2 South America Pain Patches Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Pain Patches Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Pain Patches Sales Value Share by Country, 2025 VS 2032
7 Pain Patches Country-level Sales and Value Analysis
- 7.1 Global Pain Patches Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pain Patches Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Pain Patches Sales by Country (2021-2032)
- 7.3.1 Global Pain Patches Sales by Country (2021-2026)
- 7.3.2 Global Pain Patches Sales by Country (2027-2032)
- 7.4 Global Pain Patches Sales Value by Country (2021-2032)
- 7.4.1 Global Pain Patches Sales Value by Country (2021-2026)
- 7.4.2 Global Pain Patches Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Pain Patches Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Pain Patches Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Pain Patches Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Pain Patches Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Pain Patches Sales Value Growth Rate (2021-2032)
- 7.9.2 France Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Pain Patches Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Pain Patches Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Pain Patches Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Pain Patches Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Pain Patches Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Pain Patches Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Pain Patches Sales Value Growth Rate (2021-2032)
- 7.16.2 China Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Pain Patches Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Pain Patches Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Pain Patches Sales Value Growth Rate (2021-2032)
- 7.19.2 India Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Pain Patches Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Pain Patches Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Pain Patches Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Pain Patches Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Pain Patches Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Pain Patches Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Pain Patches Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Pain Patches Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Pain Patches Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Pain Patches Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Pain Patches Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Pain Patches Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Pain Patches Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Pain Patches Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Pain Patches Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Pain Patches Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Sanofi Pain Patches Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Novartis
- 8.2.1 Novartis Company Information
- 8.2.2 Novartis Business Overview
- 8.2.3 Novartis Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Novartis Pain Patches Product Portfolio
- 8.2.5 Novartis Recent Developments
- 8.3 GlaxoSmithKline
- 8.3.1 GlaxoSmithKline Company Information
- 8.3.2 GlaxoSmithKline Business Overview
- 8.3.3 GlaxoSmithKline Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.3.4 GlaxoSmithKline Pain Patches Product Portfolio
- 8.3.5 GlaxoSmithKline Recent Developments
- 8.4 Viatris
- 8.4.1 Viatris Company Information
- 8.4.2 Viatris Business Overview
- 8.4.3 Viatris Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Viatris Pain Patches Product Portfolio
- 8.4.5 Viatris Recent Developments
- 8.5 Teva Pharmaceutical Industries
- 8.5.1 Teva Pharmaceutical Industries Company Information
- 8.5.2 Teva Pharmaceutical Industries Business Overview
- 8.5.3 Teva Pharmaceutical Industries Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Teva Pharmaceutical Industries Pain Patches Product Portfolio
- 8.5.5 Teva Pharmaceutical Industries Recent Developments
- 8.6 Teikoku Seiyaku
- 8.6.1 Teikoku Seiyaku Company Information
- 8.6.2 Teikoku Seiyaku Business Overview
- 8.6.3 Teikoku Seiyaku Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Teikoku Seiyaku Pain Patches Product Portfolio
- 8.6.5 Teikoku Seiyaku Recent Developments
- 8.7 Nichiban
- 8.7.1 Nichiban Company Information
- 8.7.2 Nichiban Business Overview
- 8.7.3 Nichiban Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Nichiban Pain Patches Product Portfolio
- 8.7.5 Nichiban Recent Developments
- 8.8 Mentholatum
- 8.8.1 Mentholatum Company Information
- 8.8.2 Mentholatum Business Overview
- 8.8.3 Mentholatum Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Mentholatum Pain Patches Product Portfolio
- 8.8.5 Mentholatum Recent Developments
- 8.9 Johnson & Johnson Services
- 8.9.1 Johnson & Johnson Services Company Information
- 8.9.2 Johnson & Johnson Services Business Overview
- 8.9.3 Johnson & Johnson Services Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Johnson & Johnson Services Pain Patches Product Portfolio
- 8.9.5 Johnson & Johnson Services Recent Developments
- 8.10 Hisamitsu Pharmaceutical
- 8.10.1 Hisamitsu Pharmaceutical Company Information
- 8.10.2 Hisamitsu Pharmaceutical Business Overview
- 8.10.3 Hisamitsu Pharmaceutical Pain Patches Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Hisamitsu Pharmaceutical Pain Patches Product Portfolio
- 8.10.5 Hisamitsu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pain Patches Value Chain Analysis
- 9.1.1 Pain Patches Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pain Patches Sales Mode & Process
- 9.2 Pain Patches Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pain Patches Distributors
- 9.2.3 Pain Patches Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst